Inhibition of Rat and Human Steroidogenesis by Triazole Antifungals
- 1 January 2009
- journal article
- Published by Informa UK Limited in Systems Biology in Reproductive Medicine
- Vol. 55 (5-6), 214-226
- https://doi.org/10.3109/19396360903234045
Abstract
Environmental chemicals that alter steroid production could interfere with male reproductive development and function. Three agricultural antifungal triazoles that are known to modulate expression of cytochrome P450 (CYP) genes and enzymatic activities were tested for effects on steroidogenesis using rat in vivo (triadimefon), rat in vitro (myclobutanil and triadimefon), and human in vitro (myclobutanil, propiconazole, and triadimefon) model systems. Hormone production was measured in testis organ cultures from untreated adult and neonatal rats, following in vitro exposure to 1, 10, or 100 muM of myclobutanil or triadimefon. Myclobutanil and triadimefon reduced media levels of testosterone by 40-68% in the adult and neonatal testis culture, and altered steroid production in a manner that indicated CYP17-hydroxylase/17,20 lyase (CYP17A1) inhibition at the highest concentration tested. Rat to human comparison was explored using the H295R (human adrenal adenocarcinoma) cell line. Following 48 h exposure to myclobutanil, propiconazole, or triadimefon at 1, 3, 10, 30, or 100 muM, there was an overall decrease in estradiol, progesterone, and testosterone by all three triazoles. These data indicate that myclobutanil, propiconazole, and triadimefon are weak inhibitors of testosterone production in vitro. However, in vivo exposure of rats to triazoles resulted in increased serum and intra-testicular testosterone levels. This discordance could be due to higher concentrations of triazoles tested in vitro, and differences within an in vitro model system lacking hepatic metabolism and neuroendocrine control.Keywords
This publication has 26 references indexed in Scilit:
- Toxicogenomic effects common to triazole antifungals and conserved between rats and humansToxicology and Applied Pharmacology, 2009
- Endocrine‐disrupting properties in vivo of widely used azole fungicidesInternational Journal of Andrology, 2007
- Endocrine-Disrupting Activities In Vivo of the Fungicides Tebuconazole and EpoxiconazoleToxicological Sciences, 2007
- Gene expression profiling in liver and testis of rats to characterize the toxicity of triazole fungicidesToxicology and Applied Pharmacology, 2006
- Development of Behavioral Sensitization to the Cocaine-Like Fungicide Triadimefon Is Prevented by AMPA, NMDa, DA D1 but Not DA D2 RECEPTOR AntagonistsToxicological Sciences, 2004
- Triadimefon and Triadimenol: Effects on Monoamine Uptake and ReleaseToxicology and Applied Pharmacology, 1996
- Comparative effects of the aromatase inhibitor R76713 and of its enantiomers R83839 and R83842 on steroid biosynthesis in vitro and in vivoThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Hyperactivity induced by triadimefon, a triazole fungicide*1Fundamental and Applied Toxicology, 1988
- Inhibition of testicular 17α-hydroxylase and 17,20-lyase but not 3β-hydroxysteroid dehydrogenase-isomerase or 17β-hydroxysteroid oxidoreductase by ketoconazole and other imidazole drugsJournal of Steroid Biochemistry, 1987
- Effects of Hyper- and Hypoprolactinernia on Gonadotropin Secretion, Rat Testicular Luteinizing Hormone/Human Chorionic Gonadotropin Receptors and Testosterone Production by Isolated Leydig CellsBiology of Reproduction, 1983